nach oben

Rheumatology International

Erschienen in:

10.06.2021 | COVID-19 | Correspondence Zur Zeit gratis

Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective

verfasst von: Javeria Tariq, Latika Gupta

Erschienen in: Rheumatology International | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Excerpt

Vaccine hesitancy is widely prevalent, and, notably, despite best efforts, no country has yet exceeded complete vaccination of more than 60% of their population. Testing times, such as a raging pandemic call for triage and gathering evidence suited to the masses, while minorities of any kind (social, ethnic, racial, and scientific) inevitably stand ignored. While global vaccination has now begun, it is imperative to focus on understanding efficacy and safety amongst the pregnant and lactating women while actively nipping rumors in the bud. …

GoncuAyhan S, Oluklu D, Atalay A et al (2021) COVID-19 vaccine acceptance in pregnant women. Int J Gynecol Obstet. https://doi.org/10.1002/ijgo.13713CrossRef

Saeed Z, Greer O, Shah NM (2020) Is the host viral response and the immunogenicity of vaccines altered in pregnancy? Antibodies 9:38. https://doi.org/10.3390/antib9030038CrossRefPubMedCentral

Schulze-Koops H, Specker C, Skapenko A (2021) Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines. RMD Open. https://doi.org/10.1136/rmdopen-2020-001553CrossRefPubMed

Velikova T (2021) Georgiev T (2021) SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Rheumatol Int 413(41):509–518. https://doi.org/10.1007/S00296-021-04792-9CrossRef

Park JK, Lee EB, Shin K et al (2021) COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: clinical guidance of the Korean College of Rheumatology. J Korean Med Sci 36:1–12. https://doi.org/10.3346/jkms.2021.36.e95CrossRef

Geisen UM, Berner DK, Tran F et al (2021) Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2021-220272CrossRefPubMed

Shimabukuro TT, Kim SY, Myers TR et al (2021) Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. https://doi.org/10.1056/NEJMoa2104983CrossRefPubMedPubMedCentral

Male V (2021) Are COVID-19 vaccines safe in pregnancy? Nat Rev Immunol 21:200–201CrossRef

Garnier M, Curado A, Billoir P, Barbay V, Demeyere M, Dacher J-N (2021) Imaging of Oxford/AstraZeneca® COVID-19 vaccine-induced immune thrombotic thrombocytopenia. Diagn Interv Imaging. https://doi.org/10.1016/j.diii.2021.04.005CrossRefPubMedPubMedCentral

10.

Velikova T (2021) Infection-acquired versus vaccine-induced immunity against COVID-19. Cent Asian J Med Hypotheses Ethics 2:29–35CrossRef

11.

Khan H, Gasparyan AY, Gupta L (2021) Lessons learned from publicizing and retracting an erroneous hypothesis on the mumps, measles, rubella (MMR) vaccination with unethical implications. J Korean Med Sci. https://doi.org/10.3346/jkms.2021.36.e126CrossRefPubMedPubMedCentral

12.

Hayakawa S, Komine-Aizawa S, Takada K et al (2021) Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan. J Obstet Gynaecol Res. https://doi.org/10.1111/jog.14748CrossRefPubMed

13.

Craig AM, Hughes BL, Swamy GK (2021) Coronavirus disease 2019 vaccines in pregnancy. Am J Obstet Gynecol 3:100295

14.

Gill L, Jones CW (2021) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibodies in neonatal cord blood after vaccination in pregnancy. Obstet Gynecol 137:894–896. https://doi.org/10.1097/AOG.0000000000004367CrossRefPubMed

15.

Adhikari EH, Spong CY (2021) COVID-19 vaccination in pregnant and lactating women. JAMA 325:1039. https://doi.org/10.1001/jama.2021.1658CrossRefPubMed

16.

Collier A-RY, McMahan K, Yu J et al (2021) Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women. JAMA. https://doi.org/10.1001/jama.2021.7563CrossRefPubMed

17.

Beharier O, Plitman Mayo R, Raz T et al (2021) Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine. J Clin Invest. https://doi.org/10.1172/JCI150319CrossRefPubMed

18.

Egerup P, Fich Olsen L, Christiansen AH, Westergaard D, Severinsen ER, Hviid KVR, Kolte AM, Boje AD, Bertelsen MMF, Prætorius L, Zedeler A, Nielsen JR, Bang D, Berntsen S, Ethelberg-Findsen J, Storm DM, Bello-Rodríguez J, Ingham A, Ollé-López J, Hoffmann ER, Wilken-Jensen C, Krebs L, Jørgensen FS, Westh H, Jørgensen HL, la Cour Freiesleben N, Nielsen HS (2021) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibodies at delivery in women, partners, and newborns. Obstet Gynecol 137:49–55. https://doi.org/10.1097/AOG.0000000000004199CrossRefPubMed

19.

Kharbanda R, Naveen R, Misra D et al (2020) Combined case record forms for collating obstetric outcomes in rare rheumatic diseases. Indian J Rheumatol 15:191. https://doi.org/10.4103/injr.injr_102_20CrossRef

Titel: Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective
verfasst von: Javeria Tariq
Latika Gupta
Publikationsdatum: 10.06.2021
Verlag: Springer Berlin Heidelberg
Schlagwort: COVID-19
Erschienen in: Rheumatology International / Ausgabe 8/2021
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-021-04918-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

16.04.2024 | Spondylitis ankylosans | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Manche Gestagene können das Risiko für Meningeome erhöhen

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2021

COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?

COVID-19 in patients with gout on colchicine

Sex hormones, autoimmunity and gender disparity in COVID-19

Post-COVID-19 exacerbation of fibrodysplasia ossificans progressiva with multiple flare-ups and extensive heterotopic ossification in a 45-year-old female patient

Tele-health interventions to support self-management in adults with rheumatoid arthritis: a systematic review

ANCA-associated vasculitis after COVID-19

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Manche Gestagene können das Risiko für Meningeome erhöhen

Update Innere Medizin